Teenager With Crohn’s Disease Gets His life Back With Cannabis


Fifteen year old Coltyn Turner who, as a result of  Crohn’s disease became so ill that he had to be confined to a wheelchair, recently testified before the Colorado State Legislature that he’d “rather be illegally alive than legally dead.”

This is because he used cannabis to treat his disease, which is illegal in his home state of Illinois. Simply in order to treat their son with cannabis, his family was forced to re-locate to Colorado.

Crohn’s disease is a severe type of inflammatory bowel disease and this is not the first time we’ve reported how cannabis has been beneficial for sufferers. Shona Banda explains how she has recovered with the use of cannabis oil here

Going back to Coltyn’s story, Collective Evolution reports:

Over the past year, Coltyn has used cannabis oil on his path to healing. He developed Crohn’s disease (that was believed to be a result of a bacterial infection), and his condition deteriorated at a rapid pace. At that point, doctors recommended turning towards holistic remedies, which is why his family began to consider cannabis oil their best option.

Coltyn Turner

Unlike with cancer, not many studies have been conducted on the effectiveness of cannabis in the treatment of inflammatory bowel diseases, but as you can see from the news report below, multiple studies are currently underway and we look forward to seeing the results.

The first report on using cannabis to treat Crohn’s was published in 2011 and concluded:

“The results indicate that cannabis may have a positive effect on disease activity, as reflected by reduction in disease activity index, and in the need for other drugs and surgery. Prospective placebo-controlled studies are warranted to fully evaluate the efficacy and side effects of cannabis in CD.” (source)

Another study, published in 2013, concluded:

“Although the primary end point of the study (induction of remission) was not achieved, a  short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects. Further studies, with larger patient groups and a nonsmoking mode of intake, are warranted.” (source)